Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Lti-291
2. 1919820-28-2
3. Gcase Activator 1
4. V9wun9uuu8
5. 5,7-dimethyl-n-(trans-4-(pentyloxy)cyclohexyl)pyrazolo(1,5-a)pyrimidine-3-carboxamide
6. Pyrazolo(1,5-a)pyrimidine-3-carboxamide, 5,7-dimethyl-n-(trans-4-(pentyloxy)cyclohexyl)-
7. 5,7-dimethyl-n-(trans-4-(pentyloxy)cyclohexyl)pyrazolo[1,5-a]pyrimidine-3-carboxamide
8. Unii-v9wun9uuu8
9. Lti291
10. Schembl17739965
11. Schembl19024862
12. Lti 291
13. Lti 291; Lti291
14. Bcp25413
15. Ex-a2518
16. S1024
17. Akos037648860
18. Ac-36113
19. Bs-15860
20. Hy-104038
21. Cs-0026754
22. D70023
23. 5,7-dimethyl-n-((1r,4r)-4-(pentyloxy)cyclohexyl)pyrazolo[1,5-a]pyrimidine-3-carboxamide
| Molecular Weight | 358.5 g/mol |
|---|---|
| Molecular Formula | C20H30N4O2 |
| XLogP3 | 3.4 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 7 |
| Exact Mass | 358.23687621 g/mol |
| Monoisotopic Mass | 358.23687621 g/mol |
| Topological Polar Surface Area | 68.5 Ų |
| Heavy Atom Count | 26 |
| Formal Charge | 0 |
| Complexity | 453 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
90
PharmaCompass offers a list of LTI-291 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right LTI-291 manufacturer or LTI-291 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred LTI-291 manufacturer or LTI-291 supplier.
PharmaCompass also assists you with knowing the LTI-291 API Price utilized in the formulation of products. LTI-291 API Price is not always fixed or binding as the LTI-291 Price is obtained through a variety of data sources. The LTI-291 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A LTI 291 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of LTI 291, including repackagers and relabelers. The FDA regulates LTI 291 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. LTI 291 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A LTI 291 supplier is an individual or a company that provides LTI 291 active pharmaceutical ingredient (API) or LTI 291 finished formulations upon request. The LTI 291 suppliers may include LTI 291 API manufacturers, exporters, distributors and traders.
LTI 291 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of LTI 291 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right LTI 291 GMP manufacturer or LTI 291 GMP API supplier for your needs.
A LTI 291 CoA (Certificate of Analysis) is a formal document that attests to LTI 291's compliance with LTI 291 specifications and serves as a tool for batch-level quality control.
LTI 291 CoA mostly includes findings from lab analyses of a specific batch. For each LTI 291 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
LTI 291 may be tested according to a variety of international standards, such as European Pharmacopoeia (LTI 291 EP), LTI 291 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (LTI 291 USP).
